BMAL2 and nasopharyngeal carcinoma: To confirm whether ARNTL2 is a regulator of metastatic ability in NPC, we performed transient overexpression or knockdown of ARNTL2 in EBV-negative (HONE1) and EBV-positive (HK-1) NPC cell lines (Fig. 2A, B).